Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia

被引：29
|
作者：
Rabello, Doralina do Amaral [1 ]
Lucena-Araujo, Antonio Roberto [2 ]
Rocha Alves-Silva, Juliana Carvalho [1 ]
Aboud Souza da Eira, Vinicius Burnett [1 ]
Cals de Vasconcellos, Maria Catarina [3 ]
de Oliveira, Fabio Morato [2 ]
Rego, Eduardo Magalhaes [2 ]
Saldanha-Araujo, Felipe [1 ]
Silva, Fabio Pittella [1 ]
机构：
[1] Univ Brasilia, Lab Mol Pathol Canc, BR-70910900 Brasilia, DF, Brazil
[2] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, BR-14048900 Ribeirao Preto, SP, Brazil
[3] Hosp Base Dist Fed, Setor Hosp Sul, Area Especial, BR-70330150 Brasilia, DF, Brazil
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2015年 / 54卷 / 01期
关键词：
Chronic lymphocytic leukemia; EZH2; Histone methyltransferase; Gene expression; Cytogenetic; ZAP-70; EXPRESSION; POLYCOMB; MECHANISMS; DIAGNOSIS; CELLS;
D O I：
10.1016/j.bcmd.2014.07.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EZH2, a histone methyltransferase, is overexpressed in several human tumors, but whether it exerts any impact in chronic lymphocytic leukemia (CLL) remains unknown. We used real time PCR to investigate the expression profile of EZH1 and EZH2 in 59 CLL patients, 10 samples of purified B-cells from healthy donors and 12 normal adult tissues. EZH2 was overexpressed in CLL patients and correlates with high white blood cell count, ZAP-70 expression and chromosomal abnormalities. EHZ1 expression does not correlate with CLL progression. EZH2 overexpression is related to a poor prognosis of CLL and could be a useful tool to assess its aggressiveness. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码：97 / 102
页数：6
相关论文
共 50 条
  • [31] Bax degradation activity is a novel poor prognosis marker of chronic lymphocytic leukemia
    Agrawal, Sainir G.
    Liu, Feng-Ting
    Wiseman, Catherine
    Shirali, Sinuf
    Liu, Hongxiang
    Lillington, Debra
    Du, Ming Qing
    Court, Denise Syndercombe
    Newland, Adrian. C.
    Gribben, John G.
    Jia, Li
    BLOOD, 2007, 110 (11) : 908A - 908A
  • [32] Relapsed or refractory chronic lymphocytic leukemia: the poor prognosis of triple hit patients
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (06): : 320 - 321
  • [33] S-MDM4 mRNA overexpression indicates a poor prognosis and marks a potential therapeutic target in chronic lymphocytic leukemia
    Liu, Ling
    Fan, Lei
    Fang, Cheng
    Zou, Zhi-Jian
    Yang, Shu
    Zhang, Li-Na
    Li, Jian-Yong
    Xu, Wei
    CANCER SCIENCE, 2012, 103 (12): : 2056 - 2063
  • [34] Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression
    Kopparapu, Pradeep Kumar
    Bhoi, Sujata
    Mansouri, Larry
    Arabanian, Laleh S.
    Plevova, Karla
    Pospisilova, Sarka
    Wasik, Agata M.
    Croci, Giorgio Alberto
    Sander, Birgitta
    Paulli, Marco
    Rosenquist, Richard
    Kanduri, Meena
    EPIGENETICS, 2016, 11 (05) : 335 - 343
  • [35] Molecular cloning of EZH2 oncogene in chronic myeloid leukemia and therapeutic prospects
    Gaspar, Juliana Costa
    de Santana, Lucas Santos
    Freire de Souza, Camila Menezes
    Caseiro, Marcos Montani
    de Souza Giuliani, Rosane Rezende
    de Souza, Cleide Barbieri
    MUNDO DA SAUDE, 2015, 39 (03): : 307 - 315
  • [36] Eradication of Chronic Myelogenous Leukemia By Inactivation of the Polycomb Group Protein EZH2
    Xie, Huafeng
    Peng, Cong
    Qi, Jun
    Cheloni, Giullia
    Das, Partha
    Huang, Jialiang
    Minh Nguyen
    Li, Shaoguang
    Bradner, James E.
    Orkin, Stuart H.
    BLOOD, 2014, 124 (21)
  • [37] Increased EZH2 Expression is Associated With Proliferation and Progression of Cervical Cancer and Indicates a Poor Prognosis
    Liu, Yueyang
    Liu, Ting
    Bao, Xiangxiang
    He, Miaolong
    Li, Ling
    Yang, Xingsheng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2014, 33 (03) : 218 - 224
  • [38] Double sword role of EZH2 in leukemia
    Safaei, Sahar
    Baradaran, Behzad
    Hagh, Majid Farshdousti
    Alivand, Mohammad Reza
    Talebi, Mehdi
    Gharibi, Tohid
    Solali, Saeed
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 : 626 - 635
  • [39] INCREASED EXPRESSION OF PIM2 GENE IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Kapelko-Slowik, K.
    Urbaniak-Kujda, D.
    Dybko, J.
    Wolowiec, D.
    Jazwiec, B.
    Slowik, M.
    Biernat, M.
    Potoczek, S.
    Kuliczkowski, K.
    HAEMATOLOGICA, 2016, 101 : 431 - 431
  • [40] CHRONIC LYMPHOCYTIC LEUKEMIA: BIOMARKERS AND PROGNOSIS
    Stamatopoulos, Kostas
    LEUKEMIA RESEARCH, 2016, 49 : S3 - S4
12345